Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease

BACKGROUND: Although immunomodulators are increasingly used in Crohn's disease (CD), a significant number of gastroenterologists still use 5-aminosalicylate (5-ASA) in combination with azathioprine (AZA) or 6-mercaptopurine (6-MP); there is limited evidence regarding the benefit of concomitant...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Gastroenterol Res Pract
Main Authors: Kwak, Min Seob, Kim, Kyung-Jo, Cheon, Jae Hee, Kim, Wan Soo, Lee, Jeong-Mi, Hwang, Sung Wook, Park, Sang Hyoung, Yang, Dong-Hoon, Ye, Byong Duk, Byeon, Jeong-Sik, Myung, Seung-Jae, Yang, Suk-Kyun
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5822780/
https://ncbi.nlm.nih.gov/pubmed/29576767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4826973
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares